Inotiv Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $3.2
- Today's High:
- $3.37
- Open Price:
- $3.34
- 52W Low:
- $3.1
- 52W High:
- $24.33
- Prev. Close:
- $3.3
- Volume:
- 182651
Company Statistics
- Market Cap.:
- $98.75 million
- Book Value:
- 10.707
- Revenue TTM:
- $582.15 million
- Operating Margin TTM:
- -2.45%
- Gross Profit TTM:
- $157.21 million
- Profit Margin:
- -58.34%
- Return on Assets TTM:
- -0.88%
- Return on Equity TTM:
- -76.46%
Company Profile
Inotiv Inc had its IPO on 1997-11-25 under the ticker symbol NOTV.
The company operates in the Healthcare sector and Diagnostics & Research industry. Inotiv Inc has a staff strength of 2,099 employees.
Stock update
Shares of Inotiv Inc opened at $3.34 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.2 - $3.37, and closed at $3.28.
This is a -0.61% slip from the previous day's closing price.
A total volume of 182,651 shares were traded at the close of the day’s session.
In the last one week, shares of Inotiv Inc have slipped by -14.36%.
Inotiv Inc's Key Ratios
Inotiv Inc has a market cap of $98.75 million, indicating a price to book ratio of 0.1918 and a price to sales ratio of 0.2714.
In the last 12-months Inotiv Inc’s revenue was $582.15 million with a gross profit of $157.21 million and an EBITDA of $41.83 million. The EBITDA ratio measures Inotiv Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Inotiv Inc’s operating margin was -2.45% while its return on assets stood at -0.88% with a return of equity of -76.46%.
In Q2, Inotiv Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 8.8%.
Inotiv Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-14.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Inotiv Inc’s profitability.
Inotiv Inc stock is trading at a EV to sales ratio of 1.0867 and a EV to EBITDA ratio of -13.4455. Its price to sales ratio in the trailing 12-months stood at 0.2714.
Inotiv Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $854.83 million
- Total Liabilities
- $121.23 million
- Operating Cash Flow
- $-4492000.00
- Capital Expenditure
- $4.48 million
- Dividend Payout Ratio
- 0%
Inotiv Inc ended 2024 with $854.83 million in total assets and $0 in total liabilities. Its intangible assets were valued at $854.83 million while shareholder equity stood at $276.06 million.
Inotiv Inc ended 2024 with $48.82 million in deferred long-term liabilities, $121.23 million in other current liabilities, 6513000.00 in common stock, $-444443000.00 in retained earnings and $94.29 million in goodwill. Its cash balance stood at $22.22 million and cash and short-term investments were $22.22 million. The company’s total short-term debt was $14,565,000 while long-term debt stood at $371.75 million.
Inotiv Inc’s total current assets stands at $203.14 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $82.77 million compared to accounts payable of $30.50 million and inventory worth $53.92 million.
In 2024, Inotiv Inc's operating cash flow was $-4492000.00 while its capital expenditure stood at $4.48 million.
Comparatively, Inotiv Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $3.28
- 52-Week High
- $24.33
- 52-Week Low
- $3.1
- Analyst Target Price
- $17.08
Inotiv Inc stock is currently trading at $3.28 per share. It touched a 52-week high of $24.33 and a 52-week low of $24.33. Analysts tracking the stock have a 12-month average target price of $17.08.
Its 50-day moving average was $4.95 and 200-day moving average was $5.6 The short ratio stood at 1.59 indicating a short percent outstanding of 0%.
Around 1901.8% of the company’s stock are held by insiders while 3717.8% are held by institutions.
Frequently Asked Questions About Inotiv Inc
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services including, computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes, general and genetic toxicology, regulated bioanalysis, biotherapeutics, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes, nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.